Advanced Therapies for Pediatric Solid Tumors Lab

We are thrilled to share our latest work, led by @sara_labiano , on the potential of combining the oncolytic virus Delta-24-RGD with a CD40 agonist to treat diffuse midline gliomas (#DMG). Published in @CellRepMed ! (1/14) 🔗doi.org/10.1016/j.xcrm…

Congratulations to our PhD student Sandra for receiving a Professional Development Award at the 2026 International Cancer Neuroscience Symposium in Houston! Proud to see our trainees recognized and contributing to the future of cancer neuroscience. #DMG #Neuroscience

Thank you again to @eqtfoundation for supporting this work and helping turn innovative science into real opportunities for children and families. 🎗️

This project will support advanced preclinical validation of POP-02 and regulatory planning toward first-in-human studies in Europe and the United States, with the ambition to initiate a Phase I clinical trial in children.

Thank you to @eqtfoundation for supporting the project led by Marta M. Alonso @pumorister and Iker Ausejo-Mauleón @IkerAusejo, which aims to develop next-generation oncolytic virus therapies for pediatric brain tumors with no curative options. eqtgroup.com/eqt-foundation…

Gracias a la @ContraCancerNAV @ContraCancerEs por impulsar investigación que mira de frente a los tumores pediátricos. 💛🎗️ #NoSurrender

En paralelo, desde nuestro laboratorio destacamos el trabajo de Carmen Ochoa @MentxuOchoa1, que investiga el uso de virus oncolíticos en osteosarcoma pediátrico, buscando mejorar tratamientos actuales y potenciar la quimioterapia de forma sinérgica.

La @ContraCancerEs financiará 17 proyectos del @CancerCCUN en la convocatoria #AECC2025. Desde nuestro laboratorio queremos destacar dos iniciativas especialmente relevantes en tumores pediátricos. contraelcancer.es/es/actualidad/…

Tras más de 15 años de trabajo desde el laboratorio hasta la clínica, Jaime Gállego @jaimegpdl junto con su equipo lidera un ensayo clínico fase II, ampliado a distintas localizaciones cerebrales, para validar seguridad y analizar con lupa la eficacia. diariodenavarra.es/noticias/navar…

Big thanks to @MattDun17 lab for this awesome @RUNDIPG merch! It just arrived and we love it! Now we are all set with a new outfit for our next race! 🏁 👉Check out the link to get yours! rundipg.myshopify.com

Nuestra PI @AnaPatinoGarcia explica la importancia de los chequeos genómicos realizados en @ClinicaNavarra y su valor preventivo y predictivo para los pacientes en este artículo de @DiariodeNavarra. diariodenavarra.es/noticias/navar…

Si queréis conocer sobre la investigación que hacemos en el laboratorio para desarrollar nuevas terapias para tumores cerebrales infantiles podéis leer esta entrevista a nuestra PI @pumorister en @larazon_es larazon.es/salud/marta-al…

Thanks to the organizers and everyone stopping by to chat! Looking forward to meet you all again! #EANO2025 #NoSurrender

Secondly, our PI @pumorister gave an exciting talk regarding how to get the transition right in the treatment for Adolescents and Young Adults with CNS tumors. A relevant problem that needs to be adressed.

We are thrilled to share that our lab has also attended #EANO2025. It has been an amazing congress, here’s a summary of the work presented. 👇

🧠 Poster 2 – Cognitive and motor effects of TIM-3 blockade in diffuse midline glioma murine models. A work presented by our PhD Student #SandraMorales and supported by @CienciaGob

☢️ Poster 1 – Exploiting conventional type 1 dendritic cells as a new therapeutic strategy to limit neurocognitive sequelae after pediatric brain tumor radiotherapy. A poster from our PhD Student @javiermarco97, co-supervised with @sara_labiano

Last week our lab was well represented at #EACR2025 conference for #CancerNeuroscience in Bilbao. In case you missed it, here’s a look at our research on this topic. 👇